Optometrists in Oskaloosa, IA Accepting Medicare

11 Optometrists found. Showing 1 - 11

James D Else, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 200 High Ave W, Oskaloosa, IA 52577 Phone: 641-673-9263    Fax: 641-673-1778

Heartland Eye Care Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1412 A Ave W, Ste C, Oskaloosa, IA 52577 Phone: 641-673-8671    Fax: 641-673-8672

Molly J Walker, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 303 N 1st St, Oskaloosa, IA 52577 Phone: 641-673-4366    Fax: 641-673-4825

Oskaloosa Vision Center Inc Optometrist Medicare: Medicare Enrolled Practice Location: 303 N 1st St, Oskaloosa, IA 52577 Phone: 641-673-4366    Fax: 641-673-4825

Central Vision Center Of Iowa Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 119 1st Ave W, Oskaloosa, IA 52577 Phone: 641-673-5658    Fax: 641-673-0979

Central Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 119 1st Ave W, Oskaloosa, IA 52577 Phone: 641-673-5658    Fax: 641-673-9379

Central Vision Center Of Oskaloosa P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 119 1st Ave W, Oskaloosa, IA 52577 Phone: 641-673-7708    Fax: 641-673-0979

Daniel Joseph Foster, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 303 N 1st St, Oskaloosa, IA 52577 Phone: 641-673-4366

Harry Craig Coen, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 303 N 1st Street, Oskaloosa, IA 52577 Phone: 641-673-4366    Fax: 641-673-4825

Dr. Cynthia E. Shoup, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 119 1st Ave W, Oskaloosa, IA 52577 Phone: 641-673-7708    Fax: 641-673-0979

Penn Central Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 High Ave W, Oskaloosa, IA 52577 Phone: 641-673-9263

News Archive

Quest Diagnostics' OVA1 ovarian cancer test cleared by the FDA

The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail to indicate malignancy.

M. D. Anderson, AstraZeneca form alliance to advance understanding of cancer-related pain

The University of Texas M. D. Anderson Cancer Center and AstraZeneca (NYSE:AZN) today announced that they will collaborate to help advance understanding of neuropathic pain caused by cancer chemotherapy, a side effect that often limits optimal therapeutic dosing in cancer treatments.

Cancer-related care has decreased since the start of COVID-19

Research from the Sidney Kimmel Cancer Center - Jefferson Health (SKCC) found significant decreases nationwide in the number of patients being seen for cancer-related care as the COVID-19 pandemic progressed during the few first months of 2020.

NIAID awards ATCC multimillion dollar MID-BRR contract

ATCC, the premier biological materials resource, services, and standards organization, has been awarded the National Institute of Allergy and Infectious Diseases, Microbiology and Infectious Diseases Biological Resource Repository ("MID-BRR") contract, ATCC announced today. The current value of the contract is $14,615,598 with the ultimate value of $115,733,409 over 7 years with an annual renewal.

Read more Medical News

› Verified 4 days ago